Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

targets the ornithine decarboxylase
(ODC) required for cell growth and
transformation. Oncogene 18: 165.
291 Jasnis, M. A., S. Klein, M. Monte, L.
Davel, d. L. Sacerdote and I. D. Algranati.
1994. Polyamines prevent
DFMO-mediated inhibition of angiogenesis.
Cancer Lett. 79: 39.
292 Takigawa, M., M. Enomoto,Y. Nishida,
H. O. Pan, A. Kinoshita and
F. Suzuki. 1990. Tumor angiogenesis
and polyamines: a-difluoromethylornithine,
an irreversible inhibitor of ornithine
decarboxylase, inhibits B16
melanoma-induced angiogenesis in ovo
and the proliferation of vascular endothelial
cells in vitro. Cancer Res. 50:
4131.
293 Luk, G. D. and R. A. J. Casero. 1987.
Polyamines in normal and cancer cells.
Adv. Enz. Reg. 26: 91.
294 Kaczmarek, L., B. Kaminska, L. Messina,
G. Spampinato, A. Arcidiacono,
L. Malaguarnera and A. Messina.
1992. Inhibitors of polyamine biosynthesis
block tumor necrosis factor-induced
activation of macrophages. Cancer
Res. 52: 1891.
295 Messina, L., G. Spampinato, A. Arcidiacono,
L. Malaguarnera, M. Pagano,
B. Kaminska, L. Kaczmarek and
A. Messina. 1992. Polyamine involvement
in functional activation of human
macrophages. J. Leuk. Biol. 52: 585.
296 Southan, G. J., C. Szabo and C. Thiemermann.
1994. Inhibition of the induction
of nitric oxide synthase by spermine
is modulated by aldehyde dehydrogenase.
Biochem. Biophys. Res. Commun.
203: 1638.
297 Szabo, C., G. J. Southan, E. Wood, C.
Thiemermann and J. R. Vane. 1994.
Inhibition by spermine of the induction
of nitric oxide synthase in J774.
2 macrophages: requirement of a
serum factor. Br. J. Pharmacol. 112: 355.
298 Hasko, G., D. G. Kuhel, A. Marton,
Z. H. Nemeth, E. A. Deitch and C.
Szabo. 2000. Spermine differentially
regulates the production of interleukin-
12 p40 and interleukin-10 and suppresses
the release of the T helper 1 cytokine
interferon-g. Shock 14: 144.
References
299 Linsalata, M., L. Amati, L. Caradonna,
D. Caccavo, E. Jirillo and
A. Di Leo. 1999. Relationship among
red blood cell polyamine content, phagocytic
activities and plasma endotoxins
in untreated colorectal cancer patients.
Oncol. Rep. 6: 1411.
300 Chamaillard, L.,V. Catros-Quemener
and J. P. Moulinoux. 1997. Synergistic
activation of macrophage activity by
polyamine deprivation and cyclophosphamide.
Anticancer Res. 17: 1059.
301 Bowlin, T. L., B. J. McKown and
K. K. Schroeder. 1989. Methyl-acetylenicputrescine
(MAP), an inhibitor of
polyamine biosynthesis, reduces the
frequency and cytolytic activity of alloantigen-induced
LyT 2.2 positive lymphocytes
in vivo. Int. J. Immunopharmacol.
11: 259.
302 Bowlin, T. L., B. J. McKown and
P. S. Sunkara. 1987. Increased ornithine
decarboxylase activity and polyamine
biosynthesis are required for optimal
cytolytic T lymphocyte induction.
Cell Immunol. 105: 110.
303 Bowlin, T. L., G. F. Davis and
B. J. McKown. 1988. Inhibition of alloantigen-induced
cytolytic T lymphocytes
in vitro with (2R,5R)-6-heptyne-
2,5-diamine, an irreversible inhibitor of
ornithine decarboxylase. Cell Immunol.
111: 443.
304 Schall, R. P., J. Sekar, P. M. Tandon
and B. M. Susskind. 1991. Difluoromethylornithine
(DFMO) arrests murine
CTL development in the late, pre-effector
stage. Immunopharmacology 21:
129.
305 Chamaillard, L.,V. Catros-Quemener,
J. G. Delcros, J. Y. Bansard, R. Havouis,
D. Desury, A. Commeurec,
N. Genetet and J. P. Moulinoux. 1997.
Polyamine deprivation prevents the development
of tumour-induced immune
suppression. Br. J. Cancer 76: 365.
306 Chamaillard, L.,V. Catros-Quemener,
J. G. Delcros, J. Y. Bansard,
R. Havouis, D. Desury, A. Commeurec,
N. Genetet and J. P. Moulinoux.
1997. Polyamine deprivation prevents
the development of tumour-induced
immune suppression. Br. J. Cancer
76: 365.
153